Try -- end of year malaise or tax loss selling not done or 8 to 3 adcom and people are being cautious or a large short position or the market is tanking and most bio's have been going down or there is absolutely no interest in accumumalating any more shares long - etcetera etcetera.
one point I would like to make to you --- as soon as someone claims no profits, sales or income on a development stage biotech I know he knows nothing about the subject.
Corporations don't have to be in america they can go anywhere they want and take there jobs with them. There are many countries where the corporate taxes are lower and amreican corps are leaving here and going there. And let's not even discuss the 4 trillion in us cash overseas that could be repatriated when the tax situation was fixed. You marxist/radical environmentalist are driving the jobs overseas.
Karl, maybe you should go back to the 60's when john kennedy, a democrat, cut taxes and tax revenues increased substantially or when reagan cut them and the same thing happened. why are you here mister marx.
What does volume have to do with it. If the shorts are shorting and the retail is selling for tax purposes and there is not a lot of long demand at the time the mm drops the price.
A lot of the selling occurs in november from the mutual funds. Now it is time for selling by individual so that is possible given that the high for the year is 33 people could be balancing the down here against other gains.
I agree but i have to ask why you respond to them. I did for a long time but nothing changes -- a basher is a basher is a basher and nothing you can say will get them off the game they get paid to play.
20+ million shares short on 88 million outstanding. the shorts manipulate the price up and down on bio because it is a long time between meaningful news and they make profits with it. in conjuction with their big ib they short and naked short using automated systems which has the effect of undermining the price like you are seeing.
it doesn't mean that this stock is not a 10 bagger -- it is -- after the data is released for phase 3, the nda is filed and the fda approves the first drug. until then it is maniuplation city.
held 20 dorris -- wrong again -- why don't you go into the after hours and trade between your two accounts. offer 100 shares at 19.50 and buy it in you other account. that will fix us.
yahoo mb rule number 1 -- you have to post immediately when you buy sell or short otherwise it is just bs. john's post that he shorted , when is up to conjecture, is just bs.
the difference is that onxx had an approved drug during 2014 with estimated sales in the 500 to 1 billion range before being bought by amgen. cldx has very promising cancer drug that should get accelerate approval with many more in the pipeline. when approved cldx will leave onxx in the dust. I project 125 to 200 by dec 2015 and who knows where after that. you will be able to retire on this.
do what others have done put the poster(s) on ignore.